
ImmunoCellular Therapeutics
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer vaccine immunotherapies.
Market cap
$11.4m
Enterprise value
$11m
Share price
$0.09 IMUC
Authorizing premium user...
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer vaccine immunotherapies.